Patients rely on implantable ports such as the Bard PowerPort to deliver chemotherapy, medications, nutrition, and other intravenous treatments safely over extended periods of treatment. For many people undergoing cancer treatment or managing other serious medical conditions, these devices are intended to make care easier—not create additional health complications.
However, thousands of lawsuits now allege that certain Bard PowerPort devices contain a defective catheter design that can degrade, crack, or fracture after implantation. Plaintiffs claim these failures have led to serious medical complications requiring additional procedures, hospitalizations, and, in some cases, life-threatening injuries.
If you or a loved one experienced complications after receiving a Bard PowerPort, understanding the current status of the litigation may help you better evaluate your legal options and what to expect as these cases continue to move through the courts.
Key Takeaways
- The Bard PowerPort lawsuits are proceeding in a federal multidistrict litigation (MDL) in the District of Arizona.
- Plaintiffs allege defects in certain Bard PowerPort catheters caused fractures, migration, infections, blood clots, and other serious complications.
- The litigation is progressing through coordinated discovery and preparation for bellwether trials.
- No global Bard PowerPort settlement has been announced as of mid 2026.
- Medical records, implant information, and imaging studies may play an important role in evaluating potential claims.
Current Status of the Bard PowerPort Litigation
The federal Bard PowerPort litigation continues to move forward before Judge David G. Campbell in the United States District Court for the District of Arizona. Since the Judicial Panel on Multidistrict Litigation centralized these cases in 2023, the court has coordinated discovery, addressed procedural issues, and established a framework for preparing representative cases for trial.
The litigation has recently entered a more advanced stage. Rather than focusing on organizational matters, the parties are now developing evidence through discovery and preparing for the bellwether trial process that often serves as an important milestone in large product liability cases.
The current litigation timeline includes:
| Litigation Milestone | Current Status |
| Federal MDL | Active in the District of Arizona |
| Coordinated discovery | Ongoing |
| Bellwether case preparation | Underway |
| Global settlement | None announced as of 2026 |
As with many multidistrict litigations, future scheduling orders could affect these timelines as discovery progresses and motions are filed and decided.
Why Are People Filing Bard PowerPort Lawsuits?
The lawsuits allege that certain Bard PowerPort devices contain defects in the catheter component that may cause the device to deteriorate or fracture after implantation. According to the allegations, pieces of the catheter can break away, migrate through the bloodstream, or contribute to serious medical complications requiring additional treatment.
Plaintiffs contend that the device maker Bard Access Systems and related defendants knew or should have known about these potential risks but failed to provide adequate warnings regarding the device's long-term safety.
It is important to note that the lawsuits do not claim that every Bard PowerPort will fail or cause complications. Instead, each case depends on the specific device involved, the injuries suffered, and the available medical evidence connecting those injuries to the implanted port.
For patients already coping with serious illnesses such as cancer, complications involving an implanted port can interrupt treatment, require additional surgeries, and create physical and emotional hardships that extend far beyond the original medical condition.
What Is Allegedly Wrong With the Bard PowerPort?
The Bard PowerPort is an implantable venous access device designed to provide long-term access to a patient's bloodstream. Physicians commonly use these ports to administer chemotherapy, intravenous medications, blood products, and other treatments that require repeated vascular access.
The lawsuits allege that certain Bard PowerPort catheters contain a design defect involving the polyurethane material used in the catheter tubing. According to the allegations, the material can degrade over time, increasing the risk that the catheter may crack, fracture, or separate after implantation.
If a catheter breaks, fragments may migrate through the bloodstream or contribute to other serious medical complications. Plaintiffs claim these risks were greater than patients and healthcare providers were led to believe, and that stronger warnings should have been provided regarding the device's long-term performance.
Contact us today for a free, no-obligation case evaluation
What Injuries Are Being Reported in Bard PowerPort Lawsuits?
The injuries alleged in the litigation vary depending on how the device failed and where the catheter fragment or resulting complication occurred. Some patients required additional surgery to remove or replace the implanted port, while others experienced medical emergencies that interrupted ongoing treatment.
Commonly reported injuries include:
| Reported Complication | Potential Medical Consequences |
| Catheter fracture | Additional procedures to remove or replace the device |
| Catheter migration | Injury to nearby organs or blood vessels |
| Blood clots (Deep Vein Thrombosis) | Circulation problems and additional treatment |
| Infection | Hospitalization and intravenous antibiotics |
| Pulmonary embolism | Potentially life-threatening emergency |
| Cardiac complications | Irregular heart rhythms or other cardiovascular injuries |
For many patients, these complications occur while they are already receiving treatment for cancer or another serious illness. Additional surgeries, delays in treatment, and unexpected hospitalizations can significantly increase both the physical and emotional burden of an already difficult medical journey.
If you or a loved one are facing additional medical hardships due to device complications, discover how non-economic losses are evaluated in our guide to pain and suffering damages.
Understanding the Difference Between the Bard PowerPort MDL and a Class Action Lawsuit
Many people refer to the Bard PowerPort litigation as a "class action," but these cases are proceeding as a multidistrict litigation (MDL) instead. An MDL allows federal lawsuits involving similar allegations to share discovery and other pretrial proceedings while allowing each plaintiff to maintain an individual claim. This approach helps improve efficiency without treating every person's injuries as identical.
As discovery continues, the court is expected to prepare representative cases for bellwether trials. These early trials allow both plaintiffs and defendants to see how juries respond to the evidence presented. Although bellwether verdicts apply only to the individual cases being tried, they often influence future settlement negotiations throughout the broader litigation.
Has There Been a Bard PowerPort Settlement?
Many people searching for information about the litigation also want to know whether a Bard PowerPort settlement has already been reached. As of mid 2026, no global settlement has been announced for the federal Bard PowerPort litigation. The cases remain in the discovery phase, and the parties continue preparing for bellwether trials.
While large multidistrict litigations sometimes resolve through negotiated settlements, there is no way to predict whether or when that may occur. The progress of discovery, court rulings, and the outcome of bellwether trials often influence future discussions.
Because each plaintiff's injuries and damages are different, any future compensation would likely depend on the specific facts of each individual case rather than a single settlement amount paid equally to everyone involved.
What Evidence Can Help Support a Bard PowerPort Lawsuit?
Every Bard PowerPort lawsuit depends on the available medical evidence. One of the first questions attorneys typically ask is whether the implanted device can be identified and whether medical records document the complications that followed.
Hospital records, operative reports, imaging studies, and follow-up treatment records often help establish when the PowerPort was implanted, what complications developed, and whether additional procedures became necessary. If the device was removed or replaced, records from the surgery may provide valuable information about the catheter's condition and the reason for the revision.
Why Identifying the Device Matters
Many patients know they received an implanted port but are unsure which manufacturer made the device. Because several companies manufacture implantable ports, confirming that the device was a Bard PowerPort is an important step when evaluating a potential claim.
Information that may help identify the device can sometimes be found in:
- Implant cards provided after surgery
- Operative reports
- Hospital medical records
- Imaging reports
- Device labels or manufacturer information documented in the patient's chart
Even if you do not have these records yourself, they may still be available through the hospital or healthcare provider that performed the implantation procedure. The FDA Manufacturer and User Facility Device Experience (MAUDE) Database allows certain people to report issues and search for information about medical devices by providing certain details. A Bard PowerPort Lawyer may help you find the information needed to support your claim.
Frequently Asked Questions About the Bard PowerPort Lawsuit
Can I File a Lawsuit If My Bard PowerPort Was Removed?
Possibly. Many plaintiffs underwent revision surgery to remove or replace the device before learning about the ongoing litigation. Medical records documenting the implantation, removal procedure, and resulting complications may still help support a potential claim.
How Do I Know If I Had a Bard PowerPort?
Your operative report, implant card, hospital records, or other medical documentation may identify the manufacturer and model of your implanted port. If you are unsure, an attorney may be able to help determine whether your device is involved in the litigation by reviewing your available medical records.
Is There a Deadline to File a Bard PowerPort Lawsuit?
Every state has its own statutes of limitations governing product liability claims, and the applicable deadline may depend on several factors, including when the injury occurred or when it was discovered. Because these deadlines can vary, it is generally helpful to learn about your legal options as soon as possible.
Will My Case Go to Trial?
Most multidistrict litigation cases do not become bellwether trials. Instead, a small number of representative lawsuits are selected to help the parties evaluate the strengths and weaknesses of the evidence. While some individual cases may eventually proceed to trial, many MDLs resolve through negotiated settlements before most plaintiffs ever appear in court.
Discover how a single post can jeopardize your payout by reading our quick guide on how social media affects your personal injury claim.
Contact The Russo Firm to Learn More About the Bard PowerPort Litigation
Complications involving an implanted medical device can leave patients facing additional surgeries, unexpected medical expenses, and difficult questions about what caused their injuries. If you experienced serious complications after receiving a Bard PowerPort, learning about your legal rights may help you decide what steps to take next.
The Russo Firm represents individuals and families harmed by defective medical devices and dangerous products. Our attorneys stay informed about developments in ongoing multidistrict litigation and can evaluate whether your circumstances may qualify for a Bard PowerPort lawsuit.
Contact The Russo Firm today for a free consultation by calling (561) 270-0913 or completing our online contact form to learn more about the current status of the Bard PowerPort litigation and your potential legal options.